Research Topics
| Jennifer CocohobaSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Improved antiretroviral refill adherence in HIV-focused community pharmaciesJennifer M Cocohoba
School of Pharmacy, University of California at San Francisco, 521 Parnassus Ave, San Francisco, CA 94143, USA
J Am Pharm Assoc (2003) 52:e67-73. 2012..To determine differences in patient characteristics, antiretroviral therapy (ART) regimen characteristics, and regimen refill adherence for human immunodeficiency virus (HIV)-focused pharmacy (HIV-P) versus traditional pharmacy (TP) users...
Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAARTJennifer M Cocohoba
Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA
AIDS Care 24:20-9. 2012..Monitoring ART quality based on concordance with expert guidelines could improve treatment outcomes in a substantial number of patients...
Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected womenJennifer Cocohoba
Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
J Acquir Immune Defic Syndr 47:377-83. 2008..HIV treatment guidelines define optimal initial antiretroviral therapy (ART)...- Raltegravir: the first HIV integrase inhibitorJennifer Cocohoba
Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, California 94143, USA
Clin Ther 30:1747-65. 2008..Raltegravir is the first integrase inhibitor to be approved by the US Food and Drug Administration for use in antiretroviral treatment- experienced adult patients with viral resistance... - The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individualsJennifer Cocohoba
Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 521 Parnassus Avenue, C 152, Box 0622, San Francisco, CA 94143, USA
Expert Rev Anti Infect Ther 7:1159-63. 2009.... - Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patientsChristie A Robinson
Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco, San Francisco, CA, USA
J Am Pharm Assoc (2003) 47:613-5. 2007 - The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected womenThomas Yi
School of Pharmacy, University of California, San Francisco, CA 94122, USA
J Acquir Immune Defic Syndr 56:253-62. 2011..To evaluate the association between enrollment into an AIDS Drug Assistance Program (ADAP) and use of highly active antiretroviral therapy (HAART) and antihypertensive therapy... - Making sense of side effectsJennifer Cocohoba
School of Pharmacy, University of California, San Francisco, USA
BETA 23:19-29. 2011..Others hesitate because medications remind them of their disease. For many, the biggest factor in deciding whether to start ART or change their current regimen is the fear of medication side effects... - A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs CaucasiansCheng Kin Lao
Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, 521 Parnassus Ave, C 152 Box 0622, San Francisco, CA 94143 0622, USA
J Natl Med Assoc 103:518-22. 2011..Although African Americans are at a higher risk of developing chronic kidney disease, there are limited data examining the influence of race on tenofovir-related nephrotoxicity... - Hormonal contraception for HIV positive womenJennifer Cocohoba
School of Pharmacy, University of California, San Francisco, USA
BETA 22:36-40. 2010.... - Potential adverse effects and inferior efficacy in ARV treatmentDonald Graves
J Natl Med Assoc 96:692-3; author reply 693. 2004